Return to revision history
Revision as of 17:59:33, 20 November 2022 by 3.221.77.51
Revision as of 5:14:48, 23 November 2022 by 3.221.77.51
Line 1: Line 1:
Five year treatment with adjuvant tamoxifen leads to around a 30 50 reduction in the recurrence rate throughout the first 10 years and a 30 reduction in mortality rates throughout the first 15 years in early ER positive breast cancer 2, 3 <a href=http://lasix.autos/>furosemide lasix</a> Women who have never had a full term pregnancy or have done so only after the age of 35 are at a higher risk of developing ovarian cancer
West to Wisconsin <a href=https://stromectol.ink/>stromectol company</a> The risk varies for each type of cancer